Clinical Study
Clinical Outcome Following Oral Potentially Malignant Disorder Treatment: A 100 Patient Cohort Study
Table 3
Logistic regression models for “disease active” status.
| Outcome | Risk factors | Univariate analysis | Multivariable analysis | Odds (95% CI) | value | Odds (95% CI) | value |
| Disease active: recurrent or further dysplasia, malignant transformation, and OSCC development | Age | 1.007 (0.976–1.040) | 0.646 | | | Sex | | | | | Females | Reference category | | | | Males | 1.448 (0.806–3.455) | 0.405 | | | Leukoplakia types | | | | | Homogenous | Reference category | | | | Nonhomogenous | 2.991 (1.160–7.713) | 0.023 | 3.319 (0.799–13.779) | 0.099 | PMDs site | | | | | FOM | Reference category | | | | Tongue | 3.381 (1.292–8.845) | 0.013 | 3.323 (0.775–14.241) | 0.106 | Other remaining sites | 2.893 (0.971–8.620) | 0.057 | 0.944 (0.171–5.218) | 0.947 | Histopathology (WHO grading) | | | | | Mid dysphasia | Reference category | | | | Moderate | 1.129 (0.350–3.641) | 0.839 | 1.960 (0.419–9.167) | 0.393 | Severe | 4.622 (1.527–13.990) | 0.007 | 5.994 (1.282–28.018) | 0.023 | CIS | 4.800 (1.123–20.479) | 0.034 | 17.104 (2.427–120.561) | 0.004 | Binary grading | | | | | Low grade | Reference category | | | | High grade | 2.828 (1.182–6.678) | 0.020 | | | Resection margin | | | | | Free margins | Reference category | | | | Dysplastic margins | 2.812 (1.073–7.371) | 0.035 | 6.562 (1.545–27.878) | 0.011 | PMDs size (mm2) | | | | | Minor < 200 | Reference category | | | | Intermediate 200–600 | 2.327 (0.944–5.740) | 0.067 | | | Major > 600 | 4.464 (1.035–18.394) | 0.045 | | |
|
|